SLDB > cautionary tweet... https://twitter.com/NSkiF1j1/status/1008692359582928896 Nicholas Skiadas MD @NSkiF1j1 I have to say @matthewherper I’m VERY CONCERNED about @fda @ScottGottliebMD lifting the clinical hold on $SLDB therapy. Massive complement activation requiring Solaris (500k a year)= danger and I see it happening again. $SLDB lowered to STRONG SELL Opportunity for $SRPT